Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Blood Flow Restriction and Aerobic Exercise in Iron Deficiency Anemia

NCT: NCT07701213 · NOT_YET_RECRUITING

NCT IDNCT07701213
StatusNOT_YET_RECRUITING
Start Date2026-07-25
Completion2026-11-05
SponsorCairo University (OTHER)
First posted
Last updated

Brief Summary

Preventing iron deficiency anemia is essential for strengthening adolescent health and ensuring their full development. Strategies such as improving nutrition, expanding the availability of iron-fortified products, implementing pharmacological prevention, and raising awareness play a crucial role in addressing this issue.

Frequently Asked Questions

What is Blood Flow Restriction and Aerobic Exercise in Iron Deficiency Anemia?

Blood Flow Restriction and Aerobic Exercise in Iron Deficiency Anemia is a clinical trial registered under NCT07701213. Current status: NOT_YET_RECRUITING.

What is the status of NCT07701213?

The current status of NCT07701213 (Blood Flow Restriction and Aerobic Exercise in Iron Deficiency Anemia) is: NOT_YET_RECRUITING.

When did Blood Flow Restriction and Aerobic Exercise in Iron Deficiency Anemia start?

Blood Flow Restriction and Aerobic Exercise in Iron Deficiency Anemia started on 2026-07-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.